Optimization of Dose Distributions for Adjuvant Locoregional Radiotherapy of Gastric Cancer by IMRT

Locoregional relapse is a problem frequently encountered with advanced gastric cancer. Data from the randomized Intergroup trial 116 suggest effectiveness of adjuvant radiochemotherapy, albeit with significant toxicity. The potential of intensity-modulated radiotherapy (IMRT) to reduce toxicity by s...

Full description

Saved in:
Bibliographic Details
Published inStrahlentherapie und Onkologie Vol. 179; no. 8; pp. 557 - 563
Main Authors Lohr, Frank, Dobler, Barbara, Mai, Sabine, Hermann, Brigitte, Tiefenbacher, Uta, Wieland, Petra, Steil, Volker, Wenz, Frederik
Format Journal Article
LanguageEnglish
Published München Springer 01.08.2003
Springer Nature B.V
Subjects
Online AccessGet full text
ISSN0179-7158
1439-099X
DOI10.1007/s00066-003-1087-z

Cover

Abstract Locoregional relapse is a problem frequently encountered with advanced gastric cancer. Data from the randomized Intergroup trial 116 suggest effectiveness of adjuvant radiochemotherapy, albeit with significant toxicity. The potential of intensity-modulated radiotherapy (IMRT) to reduce toxicity by significantly reducing maximum and median doses to organs at risk while still applying sufficient dose to the target volume in the upper abdomen was studied. For a typical configuration of target volumes and organs, a step-and-shoot IMRT plan (eight beam orientations), developed as a class solution for treatment of tumors in the upper abdomen (Figures 1 to 3), a conventional plan, a combination of the conventional plan with a kidney-sparing boost plan, and a conventional plan with noncoplanar ap and pa fields for improved kidney sparing were compared with respect to coverage of target volume and dose to organs at risk with a dose of 45 Gy delivered as the median dose to the target volume. When using the conventional three-dimensionally planned box techniques, the right kidney could be kept below tolerance, but median dose to the left kidney amounted to between 14.8 and 26.9 Gy, depending on the plan. IMRT reduced the median dose to the left kidney to 10.5 Gy, while still keeping the dose to the right kidney < 8 Gy. Liver was spared better with IMRT. Dose to the lungs was not significantly different, and dose to the spinal cord was higher (but well below tolerance) with IMRT. The dose distribution within the target volume was less homogeneous than for the conventional plans. With regard to target coverage, > 90% of prescription dose were delivered to > 90% of target volume with IMRT (Table 1). IMRT has the potential to deliver efficient doses to target volumes in the upper abdomen, while delivering dose to organs at risk in a more advantageous fashion than a conventional technique. For clinical implementation, the possibility of extensive organ motion in the upper abdomen has to be taken into account for treatment planning and patient positioning. The multitude of potential risks related to its application has to be the subject of thorough follow-up and further studies.
AbstractList Locoregional relapse is a problem frequently encountered with advanced gastric cancer. Data from the randomized Intergroup trial 116 suggest effectiveness of adjuvant radiochemotherapy, albeit with significant toxicity. The potential of intensity-modulated radiotherapy (IMRT) to reduce toxicity by significantly reducing maximum and median doses to organs at risk while still applying sufficient dose to the target volume in the upper abdomen was studied.BACKGROUND AND PURPOSELocoregional relapse is a problem frequently encountered with advanced gastric cancer. Data from the randomized Intergroup trial 116 suggest effectiveness of adjuvant radiochemotherapy, albeit with significant toxicity. The potential of intensity-modulated radiotherapy (IMRT) to reduce toxicity by significantly reducing maximum and median doses to organs at risk while still applying sufficient dose to the target volume in the upper abdomen was studied.For a typical configuration of target volumes and organs, a step-and-shoot IMRT plan (eight beam orientations), developed as a class solution for treatment of tumors in the upper abdomen (Figures 1 to 3), a conventional plan, a combination of the conventional plan with a kidney-sparing boost plan, and a conventional plan with noncoplanar ap and pa fields for improved kidney sparing were compared with respect to coverage of target volume and dose to organs at risk with a dose of 45 Gy delivered as the median dose to the target volume.PATIENT AND METHODSFor a typical configuration of target volumes and organs, a step-and-shoot IMRT plan (eight beam orientations), developed as a class solution for treatment of tumors in the upper abdomen (Figures 1 to 3), a conventional plan, a combination of the conventional plan with a kidney-sparing boost plan, and a conventional plan with noncoplanar ap and pa fields for improved kidney sparing were compared with respect to coverage of target volume and dose to organs at risk with a dose of 45 Gy delivered as the median dose to the target volume.When using the conventional three-dimensionally planned box techniques, the right kidney could be kept below tolerance, but median dose to the left kidney amounted to between 14.8 and 26.9 Gy, depending on the plan. IMRT reduced the median dose to the left kidney to 10.5 Gy, while still keeping the dose to the right kidney < 8 Gy. Liver was spared better with IMRT. Dose to the lungs was not significantly different, and dose to the spinal cord was higher (but well below tolerance) with IMRT. The dose distribution within the target volume was less homogeneous than for the conventional plans. With regard to target coverage, > 90% of prescription dose were delivered to > 90% of target volume with IMRT (Table 1).RESULTSWhen using the conventional three-dimensionally planned box techniques, the right kidney could be kept below tolerance, but median dose to the left kidney amounted to between 14.8 and 26.9 Gy, depending on the plan. IMRT reduced the median dose to the left kidney to 10.5 Gy, while still keeping the dose to the right kidney < 8 Gy. Liver was spared better with IMRT. Dose to the lungs was not significantly different, and dose to the spinal cord was higher (but well below tolerance) with IMRT. The dose distribution within the target volume was less homogeneous than for the conventional plans. With regard to target coverage, > 90% of prescription dose were delivered to > 90% of target volume with IMRT (Table 1).IMRT has the potential to deliver efficient doses to target volumes in the upper abdomen, while delivering dose to organs at risk in a more advantageous fashion than a conventional technique. For clinical implementation, the possibility of extensive organ motion in the upper abdomen has to be taken into account for treatment planning and patient positioning. The multitude of potential risks related to its application has to be the subject of thorough follow-up and further studies.CONCLUSIONIMRT has the potential to deliver efficient doses to target volumes in the upper abdomen, while delivering dose to organs at risk in a more advantageous fashion than a conventional technique. For clinical implementation, the possibility of extensive organ motion in the upper abdomen has to be taken into account for treatment planning and patient positioning. The multitude of potential risks related to its application has to be the subject of thorough follow-up and further studies.
Locoregional relapse is a problem frequently encountered with advanced gastric cancer. Data from the randomized Intergroup trial 116 suggest effectiveness of adjuvant radiochemotherapy, albeit with significant toxicity. The potential of intensity-modulated radiotherapy (IMRT) to reduce toxicity by significantly reducing maximum and median doses to organs at risk while still applying sufficient dose to the target volume in the upper abdomen was studied. For a typical configuration of target volumes and organs, a step-and-shoot IMRT plan (eight beam orientations), developed as a class solution for treatment of tumors in the upper abdomen (Figures 1 to 3), a conventional plan, a combination of the conventional plan with a kidney-sparing boost plan, and a conventional plan with noncoplanar ap and pa fields for improved kidney sparing were compared with respect to coverage of target volume and dose to organs at risk with a dose of 45 Gy delivered as the median dose to the target volume. When using the conventional three-dimensionally planned box techniques, the right kidney could be kept below tolerance, but median dose to the left kidney amounted to between 14.8 and 26.9 Gy, depending on the plan. IMRT reduced the median dose to the left kidney to 10.5 Gy, while still keeping the dose to the right kidney < 8 Gy. Liver was spared better with IMRT. Dose to the lungs was not significantly different, and dose to the spinal cord was higher (but well below tolerance) with IMRT. The dose distribution within the target volume was less homogeneous than for the conventional plans. With regard to target coverage, > 90% of prescription dose were delivered to > 90% of target volume with IMRT (Table 1). IMRT has the potential to deliver efficient doses to target volumes in the upper abdomen, while delivering dose to organs at risk in a more advantageous fashion than a conventional technique. For clinical implementation, the possibility of extensive organ motion in the upper abdomen has to be taken into account for treatment planning and patient positioning. The multitude of potential risks related to its application has to be the subject of thorough follow-up and further studies.
Background and Purpose: Locoregional relapse is a problem frequently encountered with advanced gastric cancer. Data from the randomized Intergroup trial 116 suggest effectiveness of adjuvant radiochemotherapy, albeit with significant toxicity. The potential of intensity-modulated radiotherapy (IMRT) to reduce toxicity by significantly reducing maximum and median doses to organs at risk while still applying sufficient dose to the target volume in the upper abdomen was studied. Patient and Methods: For a typical configuration of target volumes and organs, a step-and-shoot IMRT plan (eight beam orientations), developed as a class solution for treatment of tumors in the upper abdomen (Figures 1 to 3), a conventional plan, a combination of the conventional plan with a kidney-sparing boost plan, and a conventional plan with noncoplanar ap and pa fields for improved kidney sparing were compared with respect to coverage of target volume and dose to organs at risk with a dose of 45 Gy delivered as the median dose to the target volume. Results: When using the conventional three-dimensionally planned box techniques, the right kidney could be kept below tolerance, but median dose to the left kidney amounted to between 14.8 and 26.9 Gy, depending on the plan. IMRT reduced the median dose to the left kidney to 10.5 Gy, while still keeping the dose to the right kidney < 8 Gy. Liver was spared better with IMRT. Dose to the lungs was not significantly different, and dose to the spinal cord was higher (but well below tolerance) with IMRT. The dose distribution within the target volume was less homogeneous than for the conventional plans. With regard to target coverage, > 90% of prescription dose were delivered to > 90% of target volume with IMRT (Table 1). Conclusion: IMRT has the potential to deliver efficient doses to target volumes in the upper abdomen, while delivering dose to organs at risk in a more advantageous fashion than a conventional technique. For clinical implementation, the possibility of extensive organ motion in the upper abdomen has to be taken into account for treatment planning and patient positioning. The multitude of potential risks related to its application has to be the subject of thorough follow-up and further studies.[PUBLICATION ABSTRACT]
Author Dobler, Barbara
Mai, Sabine
Hermann, Brigitte
Wieland, Petra
Wenz, Frederik
Lohr, Frank
Steil, Volker
Tiefenbacher, Uta
Author_xml – sequence: 1
  givenname: Frank
  surname: Lohr
  fullname: Lohr, Frank
– sequence: 2
  givenname: Barbara
  surname: Dobler
  fullname: Dobler, Barbara
– sequence: 3
  givenname: Sabine
  surname: Mai
  fullname: Mai, Sabine
– sequence: 4
  givenname: Brigitte
  surname: Hermann
  fullname: Hermann, Brigitte
– sequence: 5
  givenname: Uta
  surname: Tiefenbacher
  fullname: Tiefenbacher, Uta
– sequence: 6
  givenname: Petra
  surname: Wieland
  fullname: Wieland, Petra
– sequence: 7
  givenname: Volker
  surname: Steil
  fullname: Steil, Volker
– sequence: 8
  givenname: Frederik
  surname: Wenz
  fullname: Wenz, Frederik
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=14991570$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/14509955$$D View this record in MEDLINE/PubMed
BookMark eNp90UFLHDEYBuBQLLpqf0AvEoT2NvXLzGQyOcpqrbAiiEJv4ZtM0maZnazJTGH315vprrR48BRInjfhy3tMDnrfG0I-M_jGAMRFBICqygCKjEEtsu0HMmNlITOQ8ucBmQETMhOM10fkOMYlAKtKWR6SI1byRDifEX2_HtzKbXFwvqfe0isfDb1ycQiuGafNSK0P9LJdjn-wH-jCax_Mr3SAHX3A1vnhtwm43kzhG5xyms6x1ybQZkNv7x4eT8lHi100n_brCXn6fv04_5Et7m9u55eLTBcs32asYmVTWy7bvDLcaG1RYAlcFzkXhtXcQo0WSqjbtmilyXVVacPzRqM2gtfFCfm6u3cd_PNo4qBWLmrTddgbP0YluADBC5Hg-Ru49GNIA0VV5zmvGBN5Qmd7NDYr06p1cCsMG_X6dwl82QOMGjsb0tAu_uekZOnF5NjO6eBjDMb-I6CmHtWuR5V6VFOPapsy4k1Gu-FvR0NA172TfAGlEKHL
CODEN STONE4
CitedBy_id crossref_primary_10_1016_j_prro_2012_03_007
crossref_primary_10_1016_j_ijrobp_2007_09_055
crossref_primary_10_1186_1748_717X_7_192
crossref_primary_10_1016_j_currproblcancer_2011_03_001
crossref_primary_10_1586_14737140_2015_1042863
crossref_primary_10_1016_j_ijrobp_2008_04_033
crossref_primary_10_1016_j_ijrobp_2004_01_001
crossref_primary_10_1016_j_ijrobp_2006_01_001
crossref_primary_10_1007_s13566_019_00374_2
crossref_primary_10_1586_14737140_7_10_1379
crossref_primary_10_1016_j_ijrobp_2008_12_036
crossref_primary_10_1016_j_meddos_2006_03_001
crossref_primary_10_1177_030089160609200107
crossref_primary_10_1259_bjr_43441736
crossref_primary_10_1016_j_ijrobp_2005_03_013
crossref_primary_10_7314_APJCP_2014_15_17_7401
crossref_primary_10_1016_j_ijrobp_2004_02_051
crossref_primary_10_1016_j_meddos_2014_04_001
crossref_primary_10_1016_j_ijrobp_2009_06_058
crossref_primary_10_1186_1471_2407_12_287
crossref_primary_10_1016_j_radonc_2004_01_001
crossref_primary_10_1007_s00066_014_0787_x
crossref_primary_10_1016_j_radonc_2006_08_013
crossref_primary_10_1007_s00066_013_0309_2
crossref_primary_10_1007_s00066_012_0254_5
crossref_primary_10_1016_j_ejso_2006_12_012
crossref_primary_10_1007_s11596_013_1193_9
crossref_primary_10_1007_s11912_008_0032_9
crossref_primary_10_3748_wjg_v12_i10_1511
crossref_primary_10_1007_s00520_013_1996_z
crossref_primary_10_1007_s13566_015_0183_x
crossref_primary_10_1186_s13014_018_1032_z
crossref_primary_10_2349_biij_6_3_e29
ContentType Journal Article
Copyright 2004 INIST-CNRS
Urban & Vogel München 2003
Copyright_xml – notice: 2004 INIST-CNRS
– notice: Urban & Vogel München 2003
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7RV
7X7
7XB
88E
8AO
8C1
8FE
8FG
8FI
8FJ
8FK
ABUWG
AFKRA
ARAPS
BENPR
BGLVJ
CCPQU
DWQXO
FYUFA
GHDGH
HCIFZ
K9.
KB0
M0S
M1P
NAPCQ
P5Z
P62
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
7X8
DOI 10.1007/s00066-003-1087-z
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
ProQuest Nursing & Allied Health Database (NC LIVE)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Public Health Database
ProQuest SciTech Collection
ProQuest Technology Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
Advanced Technologies & Aerospace Collection
ProQuest Central
Technology Collection
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
ProQuest Health & Medical Collection
Medical Database
Nursing & Allied Health Premium
Advanced Technologies & Aerospace Database
ProQuest Advanced Technologies & Aerospace Collection
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Technology Collection
ProQuest One Academic Middle East (New)
ProQuest Advanced Technologies & Aerospace Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Pharma Collection
ProQuest Central
ProQuest One Applied & Life Sciences
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Advanced Technologies & Aerospace Collection
ProQuest Public Health
ProQuest One Academic Eastern Edition
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
Advanced Technologies & Aerospace Database
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
Technology Collection
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: 8FG
  name: ProQuest Technology Collection
  url: https://search.proquest.com/technologycollection1
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1439-099X
EndPage 563
ExternalDocumentID 2230913841
14509955
14991570
10_1007_s00066_003_1087_z
Genre Journal Article
Comparative Study
Case Reports
Report
Case Study
GroupedDBID ---
-Y2
-~C
.86
.VR
04C
06C
06D
0R~
0VY
123
1N0
1SB
203
29Q
29~
2J2
2JN
2JY
2KG
2LR
2P1
2VQ
2~H
30V
3O-
4.4
406
408
409
40D
40E
53G
5RE
5VS
67Z
6NX
7RV
7X7
88E
8AO
8C1
8FE
8FG
8FI
8FJ
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AAPKM
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAWTL
AAYIU
AAYQN
AAYTO
AAYXX
AAYZH
ABAKF
ABBBX
ABBRH
ABBXA
ABDBE
ABDZT
ABECU
ABFSG
ABFTV
ABHLI
ABHQN
ABIPD
ABJNI
ABJOX
ABKCH
ABKTR
ABLJU
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABQSL
ABSXP
ABTEG
ABTKH
ABTMW
ABULA
ABUWG
ABWNU
ABXPI
ACAOD
ACBXY
ACDTI
ACGFS
ACHSB
ACHXU
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACSTC
ACZOJ
ADBBV
ADHHG
ADHIR
ADHKG
ADJJI
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEBTG
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AEZWR
AFBBN
AFDZB
AFHIU
AFKRA
AFLOW
AFOHR
AFQWF
AFWTZ
AFZKB
AGAYW
AGDGC
AGJBK
AGMZJ
AGQEE
AGQMX
AGQPQ
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHMBA
AHPBZ
AHSBF
AHWEU
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AIXLP
AJBLW
AJRNO
AJZVZ
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AMYQR
AOCGG
ARAPS
ARMRJ
ASPBG
ATHPR
AVWKF
AXYYD
AYFIA
AZFZN
B-.
BA0
BDATZ
BENPR
BGLVJ
BGNMA
BKEYQ
BMSDO
BPHCQ
BSONS
BVXVI
CAG
CCPQU
CITATION
COF
CS3
CSCUP
DARCH
DDRTE
DL5
DNIVK
DPUIP
DU5
EBD
EBLON
EBS
EIHBH
EIOEI
EJD
EMB
EMOBN
EN4
ESBYG
EX3
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ7
GQ8
GXS
H13
HCIFZ
HF~
HG5
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
IHE
IJ-
IKXTQ
IMOTQ
IWAJR
IXC
IXD
IXE
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KDC
KOV
KPH
LAS
LLZTM
M1P
M4Y
MA-
N2Q
N9A
NAPCQ
NB0
NPVJJ
NQJWS
NU0
O9-
O93
O9I
O9J
OAM
P62
P9S
PF0
PHGZM
PHGZT
PQQKQ
PROAC
PSQYO
PT4
Q2X
QOR
QOS
R89
R9I
RIG
ROL
RPX
RRX
RSV
S16
S1Z
S27
S37
S3B
SAP
SDH
SHX
SISQX
SJYHP
SMD
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZ9
SZN
T13
TSG
TSK
TSV
TT1
TUC
U2A
U9L
UDS
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WJK
WK8
WOW
X7J
YLTOR
Z45
ZMTXR
ZOVNA
ZXP
ABRTQ
IQODW
PJZUB
PPXIY
PQGLB
-5E
-5G
-BR
-EM
3V.
ADINQ
CGR
CUY
CVF
ECM
EIF
GQ6
NPM
Z7U
Z87
7XB
8FK
DWQXO
K9.
PKEHL
PQEST
PQUKI
7X8
PUEGO
ID FETCH-LOGICAL-c312z-1614b8f59d26e5eccfa7a405c3257e185f08af0408dd3d9e2c66ce52bcace7583
IEDL.DBID 7X7
ISSN 0179-7158
IngestDate Thu Sep 04 22:01:31 EDT 2025
Sat Jul 26 02:19:35 EDT 2025
Wed Feb 19 01:49:53 EST 2025
Mon Jul 21 09:14:42 EDT 2025
Tue Jul 01 01:18:13 EDT 2025
Thu Apr 24 23:11:39 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 8
Keywords Dose repartition
Human
Adjuvant radiochemotherapy
IMRT
Adjuvant treatment
Malignant tumor
Regional
Premises
Stomach cancer
Optimization
Intensity modulated radiotherapy
Cancerology
Digestive diseases
Intensity-modulated radiotherapy
Gastric cancer
Gastric disease
Language English
License http://www.springer.com/tdm
CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c312z-1614b8f59d26e5eccfa7a405c3257e185f08af0408dd3d9e2c66ce52bcace7583
Notes ObjectType-Case Study-2
SourceType-Scholarly Journals-1
content type line 14
ObjectType-Report-1
ObjectType-Feature-3
content type line 23
ObjectType-Article-4
OpenAccessLink http://hdl.handle.net/11380/1172477
PMID 14509955
PQID 822561172
PQPubID 54006
PageCount 7
ParticipantIDs proquest_miscellaneous_75707537
proquest_journals_822561172
pubmed_primary_14509955
pascalfrancis_primary_14991570
crossref_primary_10_1007_s00066_003_1087_z
crossref_citationtrail_10_1007_s00066_003_1087_z
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2003-08-01
PublicationDateYYYYMMDD 2003-08-01
PublicationDate_xml – month: 08
  year: 2003
  text: 2003-08-01
  day: 01
PublicationDecade 2000
PublicationPlace München
PublicationPlace_xml – name: München
– name: Germany
– name: Heidelberg
PublicationTitle Strahlentherapie und Onkologie
PublicationTitleAlternate Strahlenther Onkol
PublicationYear 2003
Publisher Springer
Springer Nature B.V
Publisher_xml – name: Springer
– name: Springer Nature B.V
SSID ssj0016494
Score 1.8669126
Snippet Locoregional relapse is a problem frequently encountered with advanced gastric cancer. Data from the randomized Intergroup trial 116 suggest effectiveness of...
Background and Purpose: Locoregional relapse is a problem frequently encountered with advanced gastric cancer. Data from the randomized Intergroup trial 116...
SourceID proquest
pubmed
pascalfrancis
crossref
SourceType Aggregation Database
Index Database
Enrichment Source
StartPage 557
SubjectTerms Adenocarcinoma - radiotherapy
Adenocarcinoma - surgery
Adult
Algorithms
Biological and medical sciences
Diseases of the digestive system
Dose-Response Relationship, Radiation
Female
Gastrectomy
Gastroenterology. Liver. Pancreas. Abdomen
Humans
Imaging, Three-Dimensional
Kidney - radiation effects
Liver - radiation effects
Lung - radiation effects
Medical sciences
Optimization
Pancreas
Posture
Radiation Dosage
Radiation therapy
Radiotherapy Dosage
Radiotherapy Planning, Computer-Assisted
Radiotherapy, Adjuvant
Radiotherapy, Conformal - adverse effects
Radiotherapy, Conformal - methods
Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects)
Risk Assessment
Software
Spinal Cord - radiation effects
Stomach Neoplasms - radiotherapy
Stomach Neoplasms - surgery
Stomach. Duodenum. Small intestine. Colon. Rectum. Anus
Time Factors
Tumors
Title Optimization of Dose Distributions for Adjuvant Locoregional Radiotherapy of Gastric Cancer by IMRT
URI https://www.ncbi.nlm.nih.gov/pubmed/14509955
https://www.proquest.com/docview/822561172
https://www.proquest.com/docview/75707537
Volume 179
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT9swED8NkBASmhgfI4MVP_CEFJGPOrafJigUhiigCqS-RY7tTKCt6Uj7QP96zo4bxsN48Ut8VuS78935zr8DOMwyKiNZxKEwTITdImWhTDOMUpROqUkTahwcw-Amu3zoXo3oyNfm1L6scnEmuoNaV8rekR-jIUNTj-b2x-RvaJtG2eSq76CxBCsOuQzFmY3aeAsDAdFAe-NfsJjyRVIzchiiaGvDpjAL1Wz-ziytT2SNO1Q2rS3-73s6G9TfgM_eeSQnDbe_wCcz3oTVgU-Pb4G6xQPgj39ZSaqSnFW1IWcWG9e3taoJOqnkRD_N0IOekuvKolj-cteBZCj1o3-P9WKJL6SlU6RnBeOZFC_k52B4vw0P_fP73mXouyiEKo2TeYguXbfgJRU6yQxFjpWSSXTTFDKCGTTXZcRlibrMtU61MInKMmVoUiipDEYT6Q4sj6ux2QXCCy54zDjtKm2B3QqhRGYR5QyeFDg9gGixibnyEOO208XvvAVHdvtuAUktMinL5wEctSSTBl_jo8mdd5x5o8C4LaYsCmBvwarc62Kdt5ITwEH7FZXIZkbk2FSzOmdIi3EbC-Brw99_VkaPSlD67cOV92DNFfm5wsB9WJ4-z8x3dFamRceJJI68F9uxf9GBldPzm7vhKxu-6VA
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VIgESQrxKQ6H1AS5IEUkcvw4IVbuUXbpbpGor9RYc20EgulmaXaHd_8R_ZJwX9EBvPcdjJZ4Zzzfx-BuAV5wzHek8DpUTKkxzKkJNOWYpxlLmaMJcTccwPeGjs_TTOTvfgt_dXRhfVtntifVGbUvj_5G_xUCGoR7D7fvFz9A3jfKHq10HjcYqjt36F2Zs1bvxENX7OkmOPswGo7BtKhAaGiebEBFOmsuCKZtwx_ADCi00ohaD7yUcRq8ikrpA05bWUqtcYjg3jiW50cYhuKY47y24nVLKvRPJQV9RgomHaqjE8atFzGR3iBrVnKUY28OmEAzdenMlDN5f6Ao1UjStNP6PdeuYd_QQHrRglRw21vUIttz8MdyZtsfxT8B8xg3nor3JScqCDMvKkaHn4m3baFUEQTE5tN9XiNiXZFJ61syv9e9Hcqrtt_b-19oLf9RezpCBN8RLkq_JeHo6ewpnN7LAO7A9L-duF4jMpZKxkCw11hPJ5coo7hnsHO5MODyAqFvEzLSU5r6zxo-sJ2Ou190ToHomVJFtAnjTiywaPo_rBu9f0cxfCcwTYyaiAPY6VWWt71dZb6kBHPRP0Wn9SYyeu3JVZQJlMU8UATxr9PvPzIjgFGPPr535AO6OZtNJNhmfHO_BvbrAsC5KfAHby8uVe4lAaZnv1-ZJ4MtN-8MfAnwjtg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LT9wwEB7RRUKVqqpvUlrwob1UisjLcXxAFWXZsoXdohVI3FLHdlCrslnIrqrdf9h_1bHjpOVQbpzjsRLPeOZzZvwNwLs0pSIQRehzzbifFDHzRZziKUWqmOo4otrSMYzG6dF58uWCXqzB7_YujCmrbH2iddSqkuYf-S4GMgz1GG53S1cVcdoffJxd-6aBlEm0tt00hOuyoPYs25i743Gsl7_wNFfvDfuo-vdRNDg8OzjyXcMBX8ZhtPIR_SRFVlKuolRT_LhSMIGIRuI7M42RrQwyUaLZZ0rFiutIpqnUNCqkkBqBd4zzPoB1hkEy6cH6p8Px6aRLaaQJb4jGcU1YSLM2xRpYRlOM_H5TJoabfnUrSD6aiRr1VTaNNv6PhG1EHDyBxw7Kkv3G9p7Cmp4-g42RS9Y_B_kV3dGVu-dJqpL0q1qTvmHqdU22aoKQmeyrHwvE83NyUhlOzUv7c5JMhPruboctjfBnYeQkOTBmekOKJRmOJmcv4Pxelvgl9KbVVG8CyYqMZyHLaCKVoZkruOSp4bfT6LdwuAdBu4i5dITnpu_Gz7yjarbrbuhRDU8qy1cefOhEZg3bx12Dt29p5q8EniJDygIPtlpV5c4z1Hlnxx7sdE9xS5s8jZjqalHnDGXxFMk8eNXo95-ZEd9xSl_fOfMObODeyE-G4-MteGirD23F4hvozW8W-i2iqHmx7eyTwLf73hJ_ALsbLq4
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Optimization+of+dose+distributions+for+adjuvant+locoregional+radiotherapy+of+gastric+cancer+by+IMRT&rft.jtitle=Strahlentherapie+und+Onkologie&rft.au=Lohr%2C+Frank&rft.au=Dobler%2C+Barbara&rft.au=Mai%2C+Sabine&rft.au=Hermann%2C+Brigitte&rft.date=2003-08-01&rft.issn=0179-7158&rft.volume=179&rft.issue=8&rft.spage=557&rft_id=info:doi/10.1007%2Fs00066-003-1087-z&rft_id=info%3Apmid%2F14509955&rft.externalDocID=14509955
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0179-7158&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0179-7158&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0179-7158&client=summon